For prognosis, several systematic reviews and meta-analyses have shown that elevated circulating VEGF is closely associated with overall survival or disease-free survival in patients with colorectal cancer, lung cancer, intrahepatic cholangiocarcinoma, ovarian cancer, breast cancer, and hepatocellular carcinoma (10–15). The gene discussed is VEGFA; the disease is breast carcinoma.